搜尋結果
Regeneron's blockbuster eye drug posts weaker sales due to inventory impact
Reuters· 2 日前, opens new tab missed Wall Street estimates for quarterly profit on Thursday, hurt by softer ...
Amgen investors await weight-loss drug data
Reuters· 3 日前, opens new tab investors eyeing dramatic share price gains for rivals with successful obesity ...
What Reclassifying Marijuana Would Mean for Sellers, Users
Bloomberg· 1 日前Marijuana is now legal in 24 US states for recreational purposes and in 38 states for medical ...
US Agency to Reclassify Marijuana as a Less Dangerous Drug
Bloomberg· 4 日前Have a confidential tip for our reporters? WASHINGTON (AP) — The U.S. Drug Enforcement Administ ...
Oh, Canada: U.S. Patients Don't Want Your Health Policies
Forbes· 6 日前There's never been a worse time to get sick in Canada. The Canadian government has chosen ...
Novo Nordisk drops 5% after rival Amgen teases weight-loss drug data
Reuters· 1 日前Shares in Danish drugmaker Novo Nordisk dropped as much as 5.3% on Friday, set for their ...
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
CNBC· 1 日前Amgen's stock rose more than 12% on Friday after the drugmaker teased positive initial data ...
Amgen scraps experimental weight loss pill, moves forward with injection
CNBC· 2 日前Amgen on Thursday said it will stop developing its experimental weight loss pill and instead ...
Amgen Soars as CEO Touts Experimental Obesity Drug Progress
Bloomberg· 2 日前Amgen Inc.’s shares soared after its chief executive officer said he was “very encouraged” by ...
Provisional Statistics of Retail Sales for March 2024
Bastillepost· 2 日前The Census and Statistics Department (C&SD) released the latest figures on retail sales today ...